TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3348138

Group type: EXPERIMENTAL
Intervention: Isosorbide‐5‐mononitrate 10 mg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Isosorbide‐5‐mononitrate 20 mg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Isosorbide‐5‐mononitrate 50 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 31651661

Group type: EXPERIMENTAL
Intervention: Fixed-effects ordinary least squares (OLS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conditional logistic regression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stratified Cox regression
Number of subjects: 0
Study: 30269642

Group type: EXPERIMENTAL
Intervention: Solriamfetol 300 mg
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Solriamfetol 600 mg
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Solriamfetol 1200 mg
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Phentermine 45 mg
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Phentermine 90 mg
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 27599874

Group type: EXPERIMENTAL
Intervention: Enhanced performance feedback
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Enhanced performance feedback plus patient participation
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control
Number of subjects: 67
Study: 24743717

Group type: EXPERIMENTAL
Intervention: Intramuscular olanzapine 10 mg/d
Number of subjects: 49

Group type: COMPARATOR
Intervention: Intramuscular haloperidol 7.5 mg/d
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 49
Study: 22549239

Group type: EXPERIMENTAL
Intervention: Ciprocare®XR 1000 mg ciprofloxacin (test formulation)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Cipro®XR sustained release tablet (reference formulation)
Number of subjects: 24
Study: 20927040

Group type: EXPERIMENTAL
Intervention: Ultrafiltration rates over 13 ml/h/kg
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Ultrafiltration rates between 10-13 ml/h/kg
Number of subjects: 1846

Group type: COMPARATOR
Intervention: Ultrafiltration rates up to 10 ml/h/kg
Number of subjects: 1846
Study: 18218556

Group type: COMPARATOR
Intervention: No activation
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Regular activation
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Activation on an as-needed basis
Number of subjects: 250
Study: 17081405

Group type: COMPARATOR
Intervention: Group 1 (no parental history of hypertension)
Number of subjects: 15131

Group type: EXPERIMENTAL
Intervention: Group 2 (one parent history of hypertension)
Number of subjects: 15131

Group type: EXPERIMENTAL
Intervention: Group 3 (both parents history of hypertension)
Number of subjects: 15131

Group type: EXPERIMENTAL
Intervention: Group 2 (one parent history of hypertension) after adjusting for serum total cholesterol, HDL-C, fasting glucose, BMI, and SBP
Number of subjects: 15131

Group type: EXPERIMENTAL
Intervention: Group 3 (both parents history of hypertension) after adjusting for serum total cholesterol, HDL-C, fasting glucose, BMI, and SBP
Number of subjects: 15131
Study: 12824787

Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 479
Study: 10825337

Group type: EXPERIMENTAL
Intervention: Clonidine 0.15 mg oral dose 90 min before surgery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no premedication)
Number of subjects: 20
Study: 8677193

Group type: EXPERIMENTAL
Intervention: Patients with myocardial infarction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 1725027

Group type: EXPERIMENTAL
Intervention: 2.5 mg of ramipril
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5 mg of ramipril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6440793

Group type: EXPERIMENTAL
Intervention: Ro 15-1788 30 mg (2 tablets)
Number of subjects: 6
Study: 31027098

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with methylene blue (MB) at 0.005% concentration and low intensity laser irradiation (λ = 660 nm, 9J per point, radiant exposure of 318 J/cm)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Irrigation with sterile saline and PDT (conventional MB at 0.005% concentration and irradiation with low intensity laser λ = 660 nm, 9J per point and radiant exposure of 318 J/cm)
Number of subjects: 64
Study: 29750547

Group type: EXPERIMENTAL
Intervention: Definitely called during the night
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maybe called during the night
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (no on-call)
Number of subjects: 0
Study: 26864411

Group type: EXPERIMENTAL
Intervention: Accelerated Skill Acquisition Program (ASAP)
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Dose-equivalent occupational therapy (DEUCC)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Monitoring-only occupational therapy (UCC)
Number of subjects: 361
Study: 24499460

Group type: EXPERIMENTAL
Intervention: Differentiated resistance training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Respiratory therapy (Control)
Number of subjects: 60
Study: 22869344

Group type: EXPERIMENTAL
Intervention: Older caregivers
Number of subjects: 1219
Study: 20658807

Group type: EXPERIMENTAL
Intervention: Parent-child cognitive behavioral therapy (CBT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 64
Study: 18025310

Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy
Number of subjects: 300

Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 300
Study: 16110025

Group type: EXPERIMENTAL
Intervention: DCF (docetaxel 75 mg/m2, cisplatin 75 mg/m2 on day 1, and fluorouracil 750 mg/m2/d as continuous infusion on days 1 to 5)
Number of subjects: 158

Group type: COMPARATOR
Intervention: DC (docetaxel 85 mg/m2 and cisplatin 75 mg/m2 on day 1)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: DCF
Number of subjects: 158

Group type: COMPARATOR
Intervention: DC
Number of subjects: 158
Study: 12126721

Group type: EXPERIMENTAL
Intervention: ZDV prophylaxis (group Z)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control (group C)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Symptomatic infants (group Z)
Number of subjects: 117
Study: 9649697

Group type: EXPERIMENTAL
Intervention: EMLA cream applied for 10 minutes
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: EMLA cream applied for 20 minutes
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: EMLA cream applied for 60 minutes
Number of subjects: 59
Study: 8834128

Group type: EXPERIMENTAL
Intervention: Chronic home oxygen therapy (mean 16.4 h/day) with standard pharmacological treatment (prednisone 10‐15 mg/day) for 4 years
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard pharmacological treatment (prednisone 10‐15 mg/day) alone for 4 years
Number of subjects: 18
Study: 2473061

Group type: EXPERIMENTAL
Intervention: MOPP chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MOPP/ABVD, CAD/MOPP/ABV, MOPP/ABV
Number of subjects: 0

Group type: COMPARATOR
Intervention: Limited adjuvant RT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy and RT with cytokines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Autologous bone marrow transplantation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reducing morbidity without adverse prognostic factors
Number of subjects: 0
Study: 903604

Group type: EXPERIMENTAL
Intervention: Psychologically differentiated subjects under 5% probability of noise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychologically differentiated subjects under 50% probability of noise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychologically differentiated subjects under 95% probability of noise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychologically nondifferentiated subjects under 5% probability of noise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychologically nondifferentiated subjects under 50% probability of noise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychologically nondifferentiated subjects under 95% probability of noise
Number of subjects: 0
Study: 31121331

Group type: EXPERIMENTAL
Intervention: Intra-articular injection of a mixture of 0.5ml hyaluronic acid and 0.5ml corticosteroid
Number of subjects: 16

Group type: COMPARATOR
Intervention: Arthrocentesis with Ringer solution
Number of subjects: 16
Study: 28842164

Group type: EXPERIMENTAL
Intervention: Community-based intervention by academic health professionals (Arm 2)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Community-based intervention by lay health workers (Arm 1)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Control group (Arm 3)
Number of subjects: 330
Study: 28318797

Group type: EXPERIMENTAL
Intervention: Citalopram (N=33)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Citalopram (N=51)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study: 25913263

Group type: EXPERIMENTAL
Intervention: Distal unlocked nailing
Number of subjects: 70

Group type: COMPARATOR
Intervention: Distal locked nailing
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups (locking and unlocking)
Number of subjects: 70
Study: 23378346

Group type: EXPERIMENTAL
Intervention: Intratympanic steroid (prednisolone) administered daily for 3 consecutive days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (saline solution) administered daily for 3 consecutive days
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intratympanic steroid (prednisolone)
Number of subjects: 50
Study: 21227013

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 40
Study: 17487577

Group type: EXPERIMENTAL
Intervention: Cannabis use
Number of subjects: 404

Group type: COMPARATOR
Intervention: Heavy alcohol use
Number of subjects: 404
Study: 16808624

Group type: EXPERIMENTAL
Intervention: High-dose group (internal dose median 168 mSv, external dose median 280 mSv)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Low-dose group (internal dose negligible, external dose median 22 mSv)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (no history of occupational radiation exposure)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: High-dose group
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: High-dose group, Low-dose group, Control group
Number of subjects: 47
Study: 15526507

Group type: EXPERIMENTAL
Intervention: Rovamycine 12 days 4.5 MUI iv/day as add-on therapy
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Rovamycine 12 days 4.5 MUI iv/day followed by 6 MUI/day per os for another 12 days add-on treatment
Number of subjects: 109
Study: 11051946

Group type: EXPERIMENTAL
Intervention: Winged Vialon cannulae
Number of subjects: 42

Group type: COMPARATOR
Intervention: Metal butterfly needles
Number of subjects: 42
Study: 8630132

Group type: EXPERIMENTAL
Intervention: Buffered lidocaine at body temperature (37 degrees C)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Buffered lidocaine at room temperature (20 degrees C)
Number of subjects: 40
Study: 1734586

Group type: EXPERIMENTAL
Intervention: Radiotherapy with a field size of 5 x 5 cm2
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Radiotherapy with a field size of 6 x 6 cm2
Number of subjects: 116
Study: 6699425

Group type: EXPERIMENTAL
Intervention: Topical 8-methoxypsoralen (8-MOP) with small doses of UVA irradiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 31791376

Group type: EXPERIMENTAL
Intervention: First line antihypertensive treatment
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Interim sample size reassessment
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Sample size of 600 participants
Number of subjects: 1200
Study: 29986900

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture (AA) applied bilaterally at specific points the day before surgery.
Number of subjects: 62

Group type: COMPARATOR
Intervention: No intervention (control group).
Number of subjects: 62
Study: 27222759

Group type: EXPERIMENTAL
Intervention: Passive distraction (listening to a song on headphones)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Active distraction (moving legs up and down)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Passive-active distraction (combination of both techniques)
Number of subjects: 90
Study: 24021029

Group type: EXPERIMENTAL
Intervention: SumaRT/Nap (85 mg sumatriptan + 500 mg naproxen sodium)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Naproxen sodium (500 mg)
Number of subjects: 32
Study: 21384431

Group type: EXPERIMENTAL
Intervention: Memantine treatment in mild AD patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Memantine treatment in moderate AD patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 20375338

Group type: EXPERIMENTAL
Intervention: Monovision contact lenses (MV)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Multifocal contact lenses (MTF CL)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Single-vision distance lenses (SV)
Number of subjects: 11
Study: 17851346

Group type: EXPERIMENTAL
Intervention: Rectal irrigation
Number of subjects: 9
Study: 16215966

Group type: EXPERIMENTAL
Intervention: Artificial Neural Network (ANN) classifier with features selected by POE+ACC
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: k-nearest-neighbor (k-NN) classifier
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Texture analysis (TA) of ROIs in bone marrow and fat tissue
Number of subjects: 63
Study: 12126338

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 10418585

Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication
Number of subjects: 17

Group type: COMPARATOR
Intervention: Conventional Nissen fundoplication
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Both laparoscopic and conventional Nissen fundoplication
Number of subjects: 17
Study: 7676389

Group type: EXPERIMENTAL
Intervention: Low fluoride containing toothpaste (250 ppm F)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo toothpaste (non F-toothpaste)
Number of subjects: 16
Study: 1693065

Group type: EXPERIMENTAL
Intervention: Inosine pranobex (3 g/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Inosine pranobex
Number of subjects: 50
Study: 7290868

Group type: EXPERIMENTAL
Intervention: Awareness training plus regulated‐breathing method
Number of subjects: 16

Group type: COMPARATOR
Intervention: Regulated‐breathing method only
Number of subjects: 16
Study: 30922128

Group type: EXPERIMENTAL
Intervention: Early inhaled bronchodilators
Number of subjects: 863

Group type: COMPARATOR
Intervention: No bronchodilators
Number of subjects: 863
Study: 28287004

Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 26463242

Group type: EXPERIMENTAL
Intervention: Transoral incisionless fundoplication (TIF2) procedure
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 44
Study: 23615131

Group type: EXPERIMENTAL
Intervention: PEG IFNα‐2a (135 μg once weekly) plus lamivudine (100 mg daily)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: PEG IFNα‐2a (135 μg once weekly) plus adefovir (10 mg daily)
Number of subjects: 47
Study: 21391940

Group type: EXPERIMENTAL
Intervention: Moderate-intensity physical activity intervention (PA)
Number of subjects: 424

Group type: COMPARATOR
Intervention: Successful aging control (SA)
Number of subjects: 424
Study: 19808840

Group type: COMPARATOR
Intervention: 17beta-estradiol (E(2)) supplementation
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Acute exercise
Number of subjects: 24

Group type: COMPARATOR
Intervention: Menstrual cycle phase (midfollicular and midluteal)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sex (men vs women)
Number of subjects: 24
Study: 17685744

Group type: EXPERIMENTAL
Intervention: Sertraline plus ziprasidone 80 mg/day
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Sertraline plus ziprasidone 160 mg/day
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sertraline monotherapy
Number of subjects: 64
Study: 15164103

Group type: EXPERIMENTAL
Intervention: Nutrient supplementation containing omega-3 fatty acids (1.4 g EPA, 0.211 g DHA, 0.5 g GLA) and micronutrients
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 11477493

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment (0.15 IU/kg body weight/week)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 18
Study: 9097063

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 33
Study: 7953882

Group type: EXPERIMENTAL
Intervention: Dan Jeon breathing method training group
Number of subjects: 0
Study: 2956040

Group type: EXPERIMENTAL
Intervention: semisynthetic human NPH insulin
Number of subjects: 22

Group type: COMPARATOR
Intervention: porcine NPH insulin
Number of subjects: 22
Study: 29696296

Group type: EXPERIMENTAL
Intervention: Paleolithic diet (PD)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Paleolithic diet and exercise (PD-EX)
Number of subjects: 32
Study: 27418629

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sulfonylurea
Number of subjects: 0
Study: 23876935

Group type: EXPERIMENTAL
Intervention: Autologous platelet-rich plasma (PRP)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Dextrose prolotherapy (DP)
Number of subjects: 21
Study: 23712007

Group type: EXPERIMENTAL
Intervention: Lightwand-guided nasotracheal intubation
Number of subjects: 116

Group type: COMPARATOR
Intervention: Blind nasal intubation
Number of subjects: 116
Study: 19458534

Group type: EXPERIMENTAL
Intervention: Bifrontal ultrabrief ECT
Number of subjects: 48

Group type: COMPARATOR
Intervention: Unilateral ultrabrief ECT
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Bifrontal and Unilateral ultrabrief ECT
Number of subjects: 48
Study: 19142373

Group type: EXPERIMENTAL
Intervention: Resistance Training Group (RTG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 20
Study: 16608440

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 20
Study: 12601301

Group type: EXPERIMENTAL
Intervention: Gemcitabine (300 mg/m2), Paclitaxel (70 mg/m2), Carboplatin (AUC 5)
Number of subjects: 37
Study: 11713946

Group type: EXPERIMENTAL
Intervention: Lansoprazole 15 mg daily (LAN 15)
Number of subjects: 849

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg daily (LAN 30)
Number of subjects: 849

Group type: COMPARATOR
Intervention: Ranitidine 150 mg twice a day (RAN 150)
Number of subjects: 849
Study: 9165379

Group type: EXPERIMENTAL
Intervention: Amisulpride (50 mg/daily)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Imipramine (100 mg/daily)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study: 7705093

Group type: EXPERIMENTAL
Intervention: Mifepristone 50 mg followed by 25 mg every 12 hours up to 150 mg + misoprostol 600 micrograms (Group 1)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Mifepristone 50 mg followed by 25 mg every 12 hours up to 150 mg + PG05 1 mg vaginal suppository (Group 2)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg + misoprostol 600 micrograms (Group 3)
Number of subjects: 600
Study: 3598866

Group type: EXPERIMENTAL
Intervention: Depressed confederates
Number of subjects: 144

Group type: COMPARATOR
Intervention: Anxious confederates
Number of subjects: 144

Group type: COMPARATOR
Intervention: Normal confederates
Number of subjects: 144
Study: 30439866

Group type: EXPERIMENTAL
Intervention: Parecoxib pump (PUPA group)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Fentanyl (FEN group)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Intravenous parecoxib (IVPA group)
Number of subjects: 124
Study: 28189475

Group type: EXPERIMENTAL
Intervention: Alprostadil treatment twice daily for 4 weeks
Number of subjects: 840

Group type: COMPARATOR
Intervention: Placebo treatment twice daily for 4 weeks
Number of subjects: 840
Study: 25183687

Group type: EXPERIMENTAL
Intervention: Tiotropium (18 μg once daily) plus Indacaterol (150 μg once daily)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Advair(®) (50/250 μg twice daily)
Number of subjects: 46
Study: 23212243

Group type: EXPERIMENTAL
Intervention: Intravenous recombinant tissue plasminogen activator (rt‐PA) for the treatment of acute stroke
Number of subjects: 48
Study: 21255498

Group type: EXPERIMENTAL
Intervention: Nasal high-flow (NHF) oxygen therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard high-flow face mask (HFFM) oxygen therapy
Number of subjects: 60
Study: 17532637

Group type: EXPERIMENTAL
Intervention: Neutral patella taping
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Patellofemoral bracing
Number of subjects: 12

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 12
Study: 16023780

Group type: EXPERIMENTAL
Intervention: Full thickness suturing technique
Number of subjects: 78

Group type: COMPARATOR
Intervention: Split suturing technique
Number of subjects: 78
Study: 12921941

Group type: COMPARATOR
Intervention: Combined control arm for many trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Several randomisations at the same up-front time point
Number of subjects: 0
Study: 10849039

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A, 25 U
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A, 75 U
Number of subjects: 123

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 123
Study: 9167811

Group type: EXPERIMENTAL
Intervention: Pneumatic leg brace (Aircast)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Traditional treatment (rest and gradual return to activity)
Number of subjects: 18
Study: 30251100

Group type: EXPERIMENTAL
Intervention: Meniscal repair concurrent with ACL reconstruction
Number of subjects: 44
Study: 28264824

Group type: EXPERIMENTAL
Intervention: Supervised 1-hour aerobic and resistance exercise (twice per week for 18 weeks)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 237
Study: 26255514

Group type: EXPERIMENTAL
Intervention: Catgut implantation
Number of subjects: 45

Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 45